Renal Flashcards

1
Q

Is eGFR or CrCl used for staging renal function?

A

eGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the stages of renal impairment?

A

Stage 1 (Normal GFR): >90 ml/min/1.73m2
Stage 2 (Mild impairment): 60-89
Stage 3A ( Mild to moderate): 45-59
Stage 3B (Moderate to severe): 30-44
Stage 4 (Severe): 15-29
Stage 5 (established/end stage): <15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is ureamia?

A

A build up of nitrogenous breakdown products of protein metabolism.
urea >15 mmol/L = ureamia
Can cause key symptoms in CKD patients e.g. N+V, pruritus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is uraemia never used in isolation for a renal diagnosis?

A

Because urea can also be raised in:
Dehydration
Muscle injury
infection
haemorrhage
excess protein intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is ACR?

A

Albumin:Creatinine ratio
Albumin is a protein found in blood, that should not be present in urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What ACR values should consider use of an ACE inhibitor?

A

> 70 mg/mmol in non diabetics
2.5 in male diabetics and >3.5 in female diabetics

As this indicates an increased risk of renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the qualities of ideal drugs in renal impairment?

A

Wide therapeutic index
eliminated via the liver
not nephrotoxic- may be required for co-morbidities though
Not affected by changes in fluid balance, tissue or protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 3 types of AKI?

A

Pre-renal
Intrinsic
Post-renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is pre-renal AKI and what are possible causes?

A

Impairment that happens before the kidney e.g. lack of blood supply to the kidney or decreased renal perfusion.
Causes:
- Hypovalemia (low blood volumes) e.g. in dehydration, haemorrhage, burns
- Decreased cardiac output e.g. HF, MI
- Infection
- Liver disease- decreased blood flow through the liver causes decrease in blood supply to the kidneys
- Medications e.g. ACEi, NSAIDs, Ciclosporin, Tacrolimus, Diuretics, Laxative abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is pressure in the glomerular capillaries maintained?

A

Blood comes from the afferent arteriole into the glomerular capillaries and then leaves via the efferent arteriole.

  • Prostaglandins dilate the afferent arteriole = increased blood supply to glomerular caps
  • Angiotensin II - constricts the efferent arteriole = Decreased blood out

= Together this increases hydrostatic pressure and increases filtration rate and GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the effect of taking NSAIDs or ACE/ARBs on the glomerular capillaries and filtration rate/GFR?

A
  • NSAIDs: Inhibit prostaglandins - constriction of afferent arteriole. This causes decreased renal perfusion as less blood reaches the kidney
  • ARBS/ACE: Inhibit the renin-angiotensin system = decreases angiotensin II so causes dilation of the efferent arteriole. This decreases the hydrostatic pressure as blood finds it easier to get out of the capillaries.

= decrease HP and GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Are ACE inhibitors preferable in AKI and DM?

A

They are preferable in DM as they have a long-term benefit
However, in an AKI don’t want as they decrease the filtration rate and so worsen the condition short-term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is intrinsic renal failure and its causes?

A

This is damage to renal tissue itself.
E.g.
- Glomerular damage- DM, glomerulonephritis
- Tubular- interstitial nephritis, tubular necrosis
- Renovascular e.g. HT
- infection
- nephrotoxicity- NSAIDs (can cause pre-renal and intrinsic failure)- cause vasoconstriction of afferent arteriole = decreased hydrostatic pressure = decreased filtration rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which drugs can cause directly toxic reactions (nephrotoxicity) and hypersensitivity reactions?

A

Directly toxic (more predictable):
Aminoglycosides- vancomycin, gentamicin
Amphoterecin
Ciclosporin

Hypersensitivity ( unpredictable)
phenytoin
penicillins
Cephalosporins
Allopurinol
Azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is post-renal failure and some causes?

A

Problems that occur after the kidney- obstruction to urinary flow causing back pressure into the kidney leading to damage.
e.g.
- Kidney stones- block ureter
- Structural problems e.g. tumours strictures
- Nephrotoxicity by drugs e.g. Cytotoxic drugs, sulphonamides- cause depolarisation or rate crystals in urinary tract= block
- Pressure on urinary tract e.g. enlarged prostate, BPH, ovarian tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What types of renal failure can NSAIDs or infection cause?

A

Pre-renal OR intrinsic RF
(most commonly pre)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Can AKIs be reversed?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is an AKI?

A

Rapid deterioration in renal function that if not treated and lead to organ failure and death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the diagnosis criteria for AKI?

A

CREATININE:
- increased by >26.5 micromol/L within 48 hours OR
- Increased by > 1.5 fold from their baseline value
- urine output is <0.5ml/kg/hr for 6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the stages of AKI?

A

Based on deviation from baseline creatinine:
STAGE 1: 1.5-1.9 x baseline creatinine
STAGE 2: 2-2.9 x baseline creatinine
STAGE 3: 3.0 + x baseline creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the risk factors for AKI?

A

Diabetes
CKD
Previous AKI
Hepatic disease- decreased blood flow to kidney
Congestive cardiac failure (CCF) or Peripheral vascular disease (PVD)
>65 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the possible causes of AKI?

A

Most commonly pre-renal (decreases perfusion due to decreased blood volume or hypovalemic state).
e.g.
Hypotension
infection
dehydration
sepsis
medications- NSAIDs, ACEis/ARBs, Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Signs and symptoms of AKI?

A

Volume depletion:
Thirst
Loss of fluid
Clinically dry- dry mucosae
decreased skin elasticity
tachycardia
hypotension
decreased jugular venous pressure

IF untreated, volume depletion can tip into overload- kidney has failed so can’t remove fluid

Volume overload:
Orthopnoea- SOB on lying down
Oedema (swelling of ankles)
pulmonary oedema- crackles in lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the process of treating AKI?

A
  • Identity cause
  • Medical history:
    Review and hold meds that can exacerbate AKIs e.g. ACEi, diuretics, NSAIDs
    Adjust doses to prevent harm- if renal excreted and so can accumulate e.g. DOACs, Metformin
    Remember to restart once AKI has resolved

IF DEHYDRATED: Early and aggressive fluid resuscitation to mimic fluid loss:
- if haemorrhage, give blood
- if fluid loss, give NaCl
- Monitor fluid input and ouput
- 1/3 of patients have dialysis to maintain renal function while treating underlying cause

IF FLUID OVERLOADED:
- Give loop diuretics e.g. Furosemide 1-2g IV over 24 hours. MAX RATE of 4mg/minute due to risk of ototoxicity.
Diuresis (use of diuretics)- increases renal blood flow to remove build of fluid
- Dopamine ( not commonly used, mainly in ITU)- causes renal vasodilation via DA1 receptor to increase renal perfusion and urine output. This only occurs at low doses e.g. 2mcg/kg/min, in high doses >5mcg/kg/min it has the opposite effect = vasoconstriction

OTHER TREATMENTS:
- Antibiotics if caused by an infection
- Electrolyte correction e.g. Hyperkalemia:
>6.5 mmol/L potassium= muscle weakness, ventricular fibrillation, cardiac arrest
if >6, want to treat urgently:
- Calcium glutinate IV- 30mL 10%- Ants
Antagonises K+ at cardiomyocyte membranes- protects heart from arrythmias
- Rapid-acting insulin (with glucose to prevent hypoglycaemia) over 15 mins to stimulate sodium potassium transporters to drive k+ uptake into cells.
- Nebulised salbutamol (rarely used)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the benefits/disadvantages of ACE inhibitors/ARBs long and short term in AKI?

A

ACE/ARBs: Prevent angiotensin-II mediated vasoconstriction of the efferent arteriole = vasodilation = decreased hydrostatic pressure and glomerular filtration rate.
Long-term this is protective- prevents sustained vasoconstriciton and stenosis of the efferent arteriole and loss of nephron function = good

BUT, in AKI states, reduction of hydrostatic pressure worsens AKI as we want to preserve filtration rate = HOLD ACE/ARB IN AKI and restart when treated to preserve ongoing function long-term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the max rate of furosemide delivery in AKI?

A

4mg/min due to risk of ototoxicity (hearing or balance problems)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How do you treat hyperkaleima in AKI?

A

Hyperkalemia:
>6.5 mmol/L potassium= muscle weakness, ventricular fibrillation, cardiac arrest
if >6, want to treat urgently:
- Calcium glutinate IV- 30mL 10%- Ants
Antagonises K+ at cardiomyocyte membranes- protects heart from arrythmias
- Rapid-acting insulin (with glucose to prevent hypoglycaemia) over 15 mins to stimulate sodium potassium transporters to drive k+ uptake into cells.
- Nebulised salbutamol (rarely used)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is CKD?

A

Chronic kidney disease- worsening, progressive, irreversible loss of kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the diagnosis criteria for CKD?

A

Patients with abnormalities for more than 3 months:
- eGFR less than 60mL/minute/1.73m2 on at least 2 occasions 90 days apart
- or with markers of kidney damage e.g. albuminuria, haematuria, kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are possible causes of CKD?

A
  • AKI- if irreversible intrinsic damage
  • Hypertension- vessel thickening and narrowing leads to decreased blood flow
  • Diabetic nephropathy- fibrosis, membrane thickening
  • Glomerulopathies
  • vasculitis
  • polycystic kidney disease

ALL lead to kidney sclerosis (hardening of tissue) = Blood flow is diverted to nephrons that still work causing hyperfiltration in these nephrons. this is good short term but increased pressure ling-term will lead to sclerosis in these nephrons too and loss of the nephron.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the possible complication of CKD?

A
  • Water and electrolyte imbalance- hyperkalemia, acidosis
  • uraemia
  • renal bone disease
  • renal anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How do you regulate water imbalance as a complication of CKD?

A

Fluid restriction “Turn off tap”:
- Restrict fluid intake per day to prevent water build up:
If not on dialysis and still passing urine + minimum of 1 L per day
- on dialysis will decrease to around 500mL per day
- Also sodium restriction via dietary measures
- Patients must measure their weight and BP daily at home- have a target dry weight

IF this is insufficient:

“Take plug out”- prescribe diuretics:
- first line is loop diuretics e.g. Furosemide up to 2g/day
- can use bumetanide- better absorbed patient has a lot of fluid accumulated in the abdomen
- Can use Metolazone (Thiazide-like diuretic)- very potent so needs close monitoring

Usually, diuretics are stopped when patient starts dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How do you regulate Potassium electrolytes to manage this complication of CKD?

A

Target potassium = 4-6mmol/L pre-dialysis:
- Prescribe potassium binder- Calcium resonium- binds to K+ in GI tract and removed it from the body. But, does release calcium ions in exchange which can cause constipation so co-prescribe lactulose
- Sodium Zirconium cyclosilicate- now approved by NICE for high K+ in some circumstances to allow patients o remain on ACE/ARBs for longer and at a higher dose (K+ In blood is increased as a s/e of ACE/ARB) and to increase adherence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How do you regulate bicarbonate electrolytes to manage this complication of CKD?

A

Acidosis = decreased bicarbonate ions in blood
- Sodium bicarbonate PO 500mg TDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What us uraemia?

A

Decrease in waste product excretion and so they build up in the blood.
This can cause pruritus, Anorexia, n+v, foul metallic taste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What drug can be used to manage pruritus as a result of harm-dialysis?

A

Difelikefalin- 0.5mcg/kg 3-4 times a week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the muscle dysfunction symptoms that can be caused by CKD and their treatments?

A

Cramps, restlessness especially at night or when on dialysis
Treatment:
- lifestyle measures- no caffeine or alcohol before bed, better sleep hygiene
- check iron levels
- Quinine (cramps)- 300mg ON
- Ropinorole (restlessness)- 250mcg ON

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What causes hypertension in CKD?

A

Increased sodium and water retention causes an increase in circulatory volume, leading to artery stenosis and HTN and increased rate of renal function decline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is the target BP of a patient with low proteinuria (ACR<70 or PCR <100)?

A

<140/90 mm/Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What ACR values are indicative in imitation of an ARB/ACEi?

A

If patient has CKD with HTN and ACR >30mg/mmol
OR
is diabetic and ACR >3 mg/mmol

START ACE OR ARB

ALSO, of patient doesn’t have diabetes or HTN but has an ACR 70mg/mmol+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the target BP of a patient with high proteinuria (ACR >70 or PCR >100)?

A

<130/80mm/Hg

42
Q

What ACR is indicative for needing an ACE without HTN or DM?

A

70mg/mmol+

43
Q

What are the toxic monitoring parameters for ACE/ARBs?

A
  • Potassium levels- before treatment and 1-2 weeks after
  • creatinine- 1-2 weeks after initiation
44
Q

What are you not worried about in end-stage renal failure?

A

Not worried about the effect of the drugs on creatinine more the side effects of toxic accumulation.

45
Q

When are ACE/ARBS Cid and why?

A

In renal artery stenosis-
Atheroscelrosis on main arteries supplying nthe kidneys = decreases filtration rate (GFR) due to decreased perfusion. This relies on the RAS sytsem to cause vasoconstriction of the efferent arteriole to maintain pressure in the gomeruls to maintain filtration rate.
An ACE or ARB blocks this compensatory mechansim and so leads to worsening of renal failure.

46
Q

When is dialysis used?

A

In end-stage renal failure (ESRF)
When complications/RF become unmanageable by other options. Symptoms
- Extreme fatigue
- N+V
- Pruritis
- Bone pain
- Inability to urinate
- Weight loss

47
Q

What is the average eGFR of an end-stage renal failure patient?

A

7ml/minute

48
Q

What are the principles of dialysis?

A

Dialysis tries to mimic the natural processes of the kidney:
- Mimic the glomerulus’s ultra-filtration mechanisms- remove fluid build-up via hydrostatic pressure or osmotic gradient and remove waste product build-up via diffusion.
- Mimic reabsorption throughout the nephron- by editing dialysate fluid composition to patients biochemistry to encourage reabsorption/conservation of needed molecules.

49
Q

What are the 2 types of dialysis?

A

Peritoneal dialysis
Haemodialysis

50
Q

How does hameodialysis work?

A

Takes blood from the patients body and into. machine that contains an artificial kidney made up of hollow fibres. Thos creates a semi-permeable membrane for diffusion to occur.
- It has a pump that generates hydrostatic pressure.
- Uses a dialyse filter- this cleans the blood

  • Arterial blood is taken from the body (patient must be anti-coagulated with heparin so blood doesn’t coagulate and block the tubes). Then the blood is passed through the dialyzer- has a countercurrent of dialyse fluid to bathe the blood and maximise the concentration gradient.
    Clean blood is returned ti the body via a vein and the dialyse fluids discarded.
51
Q

How does peritoneal dialysis work?

A

Uses the patients own peritoneum membrane (lines the internal organs) to mimic the glomerular basement membrane.
This membranes very blood rich and we fill the peritoneal space with dialyse fluid = allows exchange.
The peritoneal space normally only contains a small amount of fluid, so we drain dialyse fluid gradually into this space and then it drains out via gravity into a drainage bag.
uses a high concentration glucose solution = fluid moves out into dialysate fluid via osmosis

52
Q

What must a patient be given before hameodialysis?

A

Anti-coagulation via heparins so that the blood doesn’t coagulate and block the tubes.

53
Q

What does hameodialysis require?

A

Good access to the patients bloodstream with strong flow.
May use a temporary catheter (esp in emergent access) into the jugular or femoral vein.

54
Q

What are the risks of using a catheter to gain blood access for haemodialysis?

A

Increased risk of infection
Thrombosis- blood clot

55
Q

What is the gold standard for access to a patients bloodstream for haemodialysis?

A

An Arteriovenous fistula: Joining of a thick-walled artery and thin-walled vein together in the patients arm.
This is placed 6-8 weeks before the start of dialysis to allow it to mature- pressure from the artery joint into the vein so enlarges and thickens the vein so 2 large vessels are available for efficient dialysis.
- Blood leaves the hand near the wrist into the machine and then re-enters the body higher up In the arm

  • is longer lasting than a catheter and has decreased risk of infection and clots
  • Area must remain clean and protected- covered
56
Q

How is the effectiveness of dialysis monitored?

A
  • ‘Dialysis adequacy’ : How well toxins and waste products are being removed from the patients blood.
    To increase adequacy:
  • Increased blood flow rate
  • Increase size/surface of dialyser
  • Longer/more frequent dialysis sessions
57
Q

How can you increase the effeciveness of dialysis?

A
  • Increased blood flow rate
  • Increase size/surface of dialyser
  • Longer/more frequent dialysis sessions
58
Q

What kinds of things need to be monitored for safety when on dialysis?

A
  • Monitor the patients weight before and after a session to assess the fluid removal.
    We done want to offload too much fluid in one go or the patient may have side effects such as dizziness, hypotension
  • Session length needs to be worked up gradually- prevents disequilibrium syndrome- headaches, n&v, convulsions
59
Q

What is the average frequency of haemodialysis?

A

Usually 4 hour sessions, three times a week.

60
Q

What do patients need to be aware of/monitor between sessions?

A

Need to be aware of fluid accumulation:
- They should not gain more than 1.5kg between each session
- Each patient has a tailored dry weight that they should aim for
- If a patient gains 1.5kg+ they are a risk of pulmonary oedema and cardiac failure

61
Q

What is the risk of dialysis patients having too much fluid accumulation in-between sessions?

A
  • If a patient gains 1.5kg+ they are a risk of pulmonary oedema and cardiac failure
62
Q

What is a potential benefit of peritoneal dialysis over haemodialysis?

A

It can be done at home by the patients- more independence.
Does require dour exchanges a day everyday- patients need to be aseptic trained.

63
Q

How is the peritoneal spaces accessed in order for a patient to have peritoneal dialysis?

A

Requires use of an indwelling Tenckhoff catheter
Indwelling Tenckhoff catheter (curly):
* Inserted under local/general anaesthetic. Will give prophylactic antibiotics to decrease risk of infection.
* Through the abdominal wall and sits in the peritoneal space to deliver fluid.
* Cuffs and stitched on either side of the abdominal wall to hold in place – scar tissue will form and become watertight over time
* Clean technique required on changing catheter lines

64
Q

What are the 2 types of peritoneal dialsysis?

A
  • Continuous ambulatory peritoneal dialysis (CAPD)- This is the 4 x a day procedure as described previously
  • Automated peritoneal dialysis- Exchanged are carried out automatically overnight via a machine over 8-10 hours. 1-3 L of fluid id drained into the peritoneum and remains there for 1-3 hours before being replaced. this is good as it has more frequent and shorter dwell times than CAPD- increased dialysis adequacy
65
Q

What are some advantages of peritoneal dialysis?

A
  • Can be done at home-gives patient more independence
  • Less aggressive so causes less fatigue than in haemodialysis
  • Better for cardiac stability as gentle rate of fluid removal
  • Decreased anaemia as less blood loss at needling sites
  • Diet and fluid restrictions are not as strict
66
Q

What are some disadvantages of peritoneal dialysis?

A
  • Risk of peritonitis- infection of the peritoneal membrane. This can present as a cloudy drainage bag which is normally just clear fluid. This is common but serious.
  • membrane can become fibrosed and inefficient
  • Risk of hyperglycaemia due to high glucose content solutions
  • Needs lots of equipment and good technique- this is a lot of responsibility for a patient
  • Less clearance of smaller molecules e.g. urea, creatinine
67
Q

What are the diet restrictions for dialysis patients?

A
  • Healthy diet- with low fat and salt and high fibre
  • Low potassium- found in chocolate, potatoes, caffeine ( patients may eat these just before a dialysis session)
  • Low phosphate
  • High protein in CAPD- as can lose protein via CAPD
68
Q

What are the fluid restrictions for dialysis patients?

A

Fluid restrictions:
- Haemodialysis: Urine output in mLs + 500 mL of fluid intake per day
- Peritoneal dialysis: Urone output in mLs + 750mL per day

Note this includes any liquids e.g. ice cream, gravy (anything that is liquid at room temperature)

69
Q

What advice may you give to someone suffering with thirst quenching on a dialysis fluid restriction?

A

Can recommend to suck on an ice cube to quench their thirst and then spit the water out.

70
Q

What medication considerations must be considered on commencement of dialysis?

A
  • Stop any diuretics- unless residual function to pass urine
  • Acid:base balance- Stop sodium bicarbonate
  • Hypertension- monitor pre and post dialysis blood pressure- as usually removing fluid by dialysis causes a decrease in blood pressure. Medical management still required.
  • Remain on treatment for renal bone disease
  • Erythropoetin- increased risk of blood loss while on dialysis = anaemia, so erythropoietin is still required and is usually given with IV iron on dialysis
71
Q

What factors of dialysis and drugs themselves increase their likelihood of being removed via dialysis?

A
  • Low MW weight drug
  • Low plasma and protein binding
  • low volume of distribution
  • High water solubility
  • High renal clearance

Dialysis factors:
- Dialysis time- HD more
- Duration of dialysis
- Fluid composition, conc and volume of dialysis fluid = increased adequacy (PD)
- The pathophysiology of the peritoneum- if fibrosed= less effective removal
- Blood flow rate = if increased rate = increases pressure and loss (HD)

72
Q

Where do you find information for the doses of drugs to give in dialysis?

A

Renal drug hanboook
- For dialysis patients look at the GFR (ml/min) <10 category

73
Q

How may peritonitis be detected and what is the treatment?

A

Presentation of a cloudy drainage bag- is normally clear.
Treatment: IV Vancomycin + oral Ciprofloxacin (bioavailability of IV & PO Cipro is the same)- covers both gram negative and positive bacteria.
Vancomycin can be given into port of catheter.

74
Q

Alongside ARBs/ACE inhibitors, what other anti-hypertensives can or can’t be used and why?

Discuss- CCBs, diuretics, b-blockers, alpha blockers, vasodilators

A
  • CCBs- can cause ankle oedema- especially Nifedipine- be aware as often have to manage fluids in kidney patients
  • Diuretics- mainly for oedema rather than HTN. Thiazide-like are ineffective if CrCl is less than 25mL/minute (don’t work). Potassium-sparing- increase the risk oh hyperkalemia further
  • beta blockers- need to be cardio selective and start low, go slow. Metoprolol is ideal as it is hepatic ally cleared.
  • Alpha blockers e.g. Doxazosin is hepatically cleared
  • Vasodilators- last resort as they have side effects that often cause co-prescribing e.g. tachycardia, fluid retention and minoxidil causes hair growth
75
Q

How are SGLT-2 inhibitors thought to exert their renal protective effect?

A

SGLT2 inhibitors have a renal protective effect and slow the progression of and decrease adverse outcomes. The MOA is not fully known, but is though to:
- Prevent the reabsorption of sodium, so that sodium remains in the nephron and can reach the macular denser in the distal tubule.
Here it activates adenosine, which causes the gentle vasoconstriction of the afferent arteriole and decreasing the pressure in the glomerulus. This allows for the preserving of the kidney function and decreased damage causes by high hydrostatic pressure.

76
Q

What is the licenced SGLT-2 for CKD?

A

Dapagliflozin

77
Q

When may you start an SGLT-2 in CKD?

A
  • Used as an add on when highest dose ACE/ARB is already in place.
  • only start when eGFR is 25-75 ml/min/1.73m2 at the start of treatment with T2DM
  • Or urine ACR of at least 22.66 mg/mmol
78
Q

When would you hold an SGLT-2 inhibitor?

A

When the patient is acutely unwell, in dehydration or an acute hospital admission = risk of DKA

79
Q

What are the 2 MHRA warnings for use of SGLT-2 inhibitors?

A
  • DKA- can be euglycamic- in DKA but blood glucose is normal, therefore need to monitor the patients ketones.
  • Fournier’s gangrene- an unpleasant genital infection- encourage the patient to keep the area dry, clean and to report any itching or pain.
80
Q

What are the possible symptoms of DKA?

A

nausea and vomiting, abdominal pain, rapid breathing, excessive thirst, excessive urine production, confusion and “pear-drop” smell on the breath

81
Q

What do you do if a patient on a SGLT-2 inhibitor develops DKA or Fourniere’s gangrene?

A

If either of these side effects occur your SGLT-2 Inhibitor must be stopped immediately and not restarted

82
Q

How do you manage HTN in a patient with CKD, HTN and ACR of 30mg/mmol or less?

A

CKD, HTN and ACR of 30mg/mmol or less - follow NICE hypertension guidelines

83
Q

What causes renal bone disease?

A

This occurs particularly in CKD stages 4 and 5:
- Hyperphosphatemia
- Low vitamin D
- Hypocalcaemia

84
Q

How does hyperphosphatemia contribute to renal bone disease?

A

Less excretion of phosphate by the kidneys = causes a build up of phosphate in the blood. This can cause pruritus.

85
Q

How does low vitamin D contribute to renal bone disease?

A

Due to less activation of vitamin D- we obtain vitamin D from the sunlight in its inactive version. We convert this to the active version of active Calcitrol by hydroxylation in position 25 in the liver and then position 1 in the kidney. In CKD, this kidney step is impaired = ineffective hydroxylation and activation pf vit D = defective bone mineralisation osteomalacia (bone softening)

86
Q

How does hypocalceamia contribute to renal bone disease?

A

This is the main cause- a decrease in vitamin D means less calcium can be absorbed from the GIT and the kidneys. This means less calcium reaches the blood.
- Additionally, more phosphate in the blood means an increased sequestering of calcium to calcium phosphate in the bones occurs.

87
Q

What can hypocalceiuma, low vit-D and hyperphosphatemia lead to?

A

They can leas to issues associated with the parathyroid glands and the metabolism calcium and phosphate is controlled by the parathyroid hormone (PTH). The parathyroid glands detect Low calcium in the blood and then release PTH which stimulates an increase in calcium in the blood by 2 main routes:
- Kidney = isn’t working in CKD
- Bone
Therefore, all effort is pushed down the bone route.
There is an increased in bone turnover to release Ca2+ from the bone into the bloodstream to counteract hypocalciemia. But this can cause the bone to become damaged:
Osteoporosis
Osteotis
Osteopenis
Osteosclerosis
and increased fracture risk
HOWEVER, this is still insufficient to control the problem and so can lead to secondary hyperparathyroidism = enlargement of parathyroid glands.

88
Q

How do you manage the hyperphosphatemia part of renal bone disease?

A
  • decrease dietary phosphate intake- which is high in foods such as meat, poultry, fish, nuts, beans and a preservative in fast foods.
  • Prescribe phosphate binders which bind with phosphate in the gut to be removed
    1st line: Calcium acetate, can also use Sevlamer, Lanthanum
  • These should be taken with a meal and dose according to the size of said meal
  • these currently have adherence issues as they are large tablets, a patient may have to take a few and can have GI side effects e.g. N+V, constipation.
    Therefore, if phosphate is high, check adherence!
89
Q

How do you manage the Hypocalcemia and low vit D part of renal bone disease?

A
  • Vitamin D3 analogue e.g. Calcitrol or Alfracalcidol. CAN’T give Cholecalciferol as it is deactivated and patients with CKD can’t activate it
  • Increased vit D = increased calcium absorption
90
Q

How do you manage the hyperparathyroidism part of renal bone disease?

A

This is enlargement of PT glands- just requires effective management of phospahate, VitD, calcium
- Parathyroidectomy as a last resort
- May give Cinacalet - lowers PTH levels by increasing sensitivity of calcium receptors

91
Q

What are the PTH, phosphate and calcium targets in renal bone disease?

A

PTH: >2 x and <4 x the upper limit of normal
Phosphate: 1/1.5 mmol/L
Calcium: 2.2-2.6 mmol/L

92
Q

When is renal anemia common?

A

In CKD sated 3+

93
Q

What causes renal anemia in CKD?

A
  • Low levels of the hormone erythropoietin- a hormone synthesised by the kidney in response to low oxygen levels in this tissue = stimulates RBC proliferation in the bone marrow = more RBCs to carry oxygen to. tissues and solve hypoxia

BUT
In CKD, there is a decreased erythropoietin production so there is a decreased in RBC proliferation in the bone marrow and this leads to aneamia.
Symtpomd:
Fatigue, breathlessness,

94
Q

How do you treat renal anaemia?

A

Recombinant erythropoietin by iV/SC injection e.g.
Epoetin Alfa (Eprex)
Epoetin beta
Darbopoetin
- Side effects (not many): HTN, Eprex can cause red cell aplasia
- Or Roxadustat (rarely used)- is a hypoxia inducible factor stabiliser- boosts the gene expression of erythropoiesis to increase haemoglobin production and improve iron response.

95
Q

What is the target Hb in CKD?

A

100-120 g/L

96
Q

What must be sufficient in order for recombinant erythropoietins to be effective?

A

MUST have sufficient iron stores before giving an Epo injection as Epo stimulates the production of RBCs and iron is necessary to form the haem group to transport the oxygen to tissues.
If the patient has low iron, there is decreased epo efficacy.
= Therefore, give an iron replacement first

97
Q

What is the target ferritin range?

A

200-500 mcg/L

98
Q

What iron may be given to a patient to replenish iron stores prior to epo?

A

In earlier stages of CKD, oral iron is sufficient, but often an IV replacement e.g. Ferinject is needed- if serum ferritin is <200mcg/L

99
Q

Why should you avoid blood transfusions in CKD patients (even if have renal anemia)?

A

Because these patients may be/become a candidate for a kidney transplant, and blood transfusions increase the risk of a graft rejection.

100
Q

What vitamin replacements may be needed in CKD patients?

A
  • Renavit- contains all water-soluble vitamins needed
    Especially in dialysis patients as these vitamins get removed.
  • Also give dietary advice
101
Q

What vaccination should CKD patients be encouraged to have?

A
  • 5 yearly booster for all CKD patients with blood manipulation, particularly
    haemodialysis (monitored yearly for antibodies)
  • Doses are doubled at 3x 40mcg doses